ß-Hydroxy-ß-Methylbutrate (HMB) supplementation and functiOnal OutcomeS in multi-Trauma patients (BOOST TRIAL)
- Conditions
- Multi-traumaCritical IllnessInjuries and Accidents - Other injuries and accidents
- Registration Number
- ACTRN12620001305910
- Lead Sponsor
- The Royal Melbourne Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 51
a.Adults, 18 years of age and older
b.Completed two full calendar days in ICU
c.The predominant reason for ICU admission was a traumatic injury
d.Allowed enteral/ oral nutrition at the time of randomization
Inclusion criteria for the muscle biopsy sub group as above.
a. Death during ICU admission deemed to be inevitable
b. Bilateral above knee amputation
c. Patients assessed as requiring completely or predominantly parenteral nutrition
d. Pregnancy
e. Primary neuromuscular pathology present or strongly suspected this admission episode
f. Presumed transection of the spinal cord at any level
g. Medical decision treatment maker, participant or medical practitioner declined consent
h. Limited research availability over enrolment timeframe
I. Enrollment conflict with other research studies
j. Unlikely to be able to participate in long term follow up measures
k. Unable to obtain consent within 7 days from initial traumatic injury
Additional exclusion criteria for the muscle biopsy sub-group:
g.Not mechanically ventilated at the time of enrollment or predicted to be extubated within 48 hours of enrollment.
h.Present or strongly suspected disseminated cancer of any kind
i.Bleeding diathesis (corrected INR > 1.5 and/or APTT > 50 sec), or receiving any anticoagulant medication beyond that required for venous thromboembolism prophylaxis, or any antiplatelet drug other than low dose aspirin
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method